Information storage and data center company Iron Mountain has signed a 6MW prelease with an undisclosed US-based Fortune 100 customer for its AZP-2 data center. The lease at the Phoenix, Arizona, data ...
LYON, France and NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and metabolic diseases, today ...
LYON, France and CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today ...
Alizé Pharma SAS has announced the completion of two Phase I clinical trials with its unacylated ghrelin analog AZP-531 in 76 healthy volunteers and overweight or obese subjects. The results to date ...
Lyon, France, March 2, 2015 - Alizé Pharma, a company specialized in the development of drugs for the treatment of metabolic disorders and rare diseases, today announces the launch of a Phase II ...
Amolyt Pharma Announces Two Presentations, Including Phase 2a Data for AZP-3601 in Patients with Hypoparathyroidism, at the American Society for Bone and Mineral Research 2022 Annual Meeting Company ...
BOSTON--(BUSINESS WIRE)-- Iron Mountain Incorporated (NYSE: IRM), the storage and information management services company, today announced that it has signed a six megawatt data center pre-lease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results